Statement Of Changes In Equity [Abstract]

Cinclus Pharma Holding AB - Filing #5879290

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through exercise of warrants, equity	– SEK	2 870 SEK	– SEK	– SEK	2 870 SEK	– SEK	– SEK	2 444 SEK	2 444 SEK	– SEK
Increase (decrease) through transactions with owners, equity	411,000 SEK	797 497 SEK	– SEK	794 216 SEK	2 870 SEK	– SEK	167,000 SEK	2 277 SEK	2 444 SEK	– SEK
Share issue related cost	– SEK	58 424 SEK	– SEK	58 424 SEK	– SEK	– SEK	167,000 SEK	167,000 SEK	– SEK	– SEK